Literature DB >> 17499347

Myeloid sarcoma of the vulva as the presenting symptom in a patient with acute myeloid leukemia.

Cağatay Erşahin1, Gulbeyaz Omeroglu, Ronald K Potkul, Alia Salhadar.   

Abstract

BACKGROUND: Myeloid sarcoma is a tumor of myeloblasts or immature myeloid cells occurring in an extramedullary site. Myeloid sarcoma of female genital tract is very rare with no cases of vulvar location reported in English-language literature. CASE: A 73-year-old female presented with an indurated mass encompassing her left labia majora and vulva. The mass was diagnosed as vulvar myeloid sarcoma. The patient's peripheral blood smear revealed Auer rods and other findings consistent with a diagnosis of acute myeloid leukemia (M-2 type, FAB classification).
CONCLUSION: To the best of our knowledge this case is the first report in the English-language literature of the myeloid sarcoma of the vulva. Correct diagnosis of myeloid sarcoma in an otherwise asymptomatic patient is crucial for early administration of antileukemic chemotherapy.

Entities:  

Mesh:

Year:  2007        PMID: 17499347     DOI: 10.1016/j.ygyno.2007.03.040

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Myeloid Sarcoma Of Vulva: A Short Update.

Authors:  Kamal Kant Sahu; Ankur Jain; Uday Yanamandra; Subhash Chander Varma; Pankaj Malhotra
Journal:  Indian J Hematol Blood Transfus       Date:  2016-03-01       Impact factor: 0.900

Review 2.  Vulvar myeloid sarcoma as the presenting symptom of acute myeloid leukemia: a case report and literature review of Chinese patients, 1999-2018.

Authors:  Xilin Zhang; Peichen Huang; Zhuo Chen; Xinling Bi; Ying Wang; Jianhua Wu
Journal:  Diagn Pathol       Date:  2019-11-07       Impact factor: 2.644

3.  Vulvovaginal myeloid sarcoma with massive pelvic floor infiltration: A case report and review of literature.

Authors:  Jia-Xi Wang; Heng Zhang; Gang Ning; Li Bao
Journal:  World J Clin Cases       Date:  2022-08-16       Impact factor: 1.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.